LMAT EBITDA | LEMAITRE VASCULAR, INC.

LEMAITRE VASCULAR, INC. (LMAT) EBITDA

2026-06-30: Basis Reported; EBITDA $23.06M*; Operating income $20.40M; Depreciation and amortization $2.66M*.
2026-03-31: Basis Reported; EBITDA $20.4M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA $21.44M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA $22.93M*; Operating income $20.31M; Depreciation and amortization $2.61M*.

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$23.06M*	$20.40M	$2.66M*	(m)	(m)	(m)	$15.96M*	$19.62M	$4.85M	(m)	$5.14M
2026-03-31	Reported	$20.4M	(m)	(m)	(m)	30.65%	(m)	$15.09M	$18.16M	$4.06M	(m)	$3.99M
2025-12-31	Reported	$21.44M	(m)	(m)	(m)	33.26%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	$22.93M*	$20.31M	$2.61M*	(m)	(m)	(m)	$28.76M*	$15.09M	$2.97M	(m)	$5.21M
2025-06-30	Reported	$18.79M*	$16.14M	$2.65M*	(m)	(m)	(m)	$20.29M*	$19.26M	$3.54M	(m)	$4.29M
2025-03-31	Reported	$15.18M	(m)	(m)	(m)	25.35%	(m)	$9.04M	$18.45M	$4.09M	(m)	$3.23M
2024-12-31	Reported	$15.27M	(m)	(m)	(m)	27.41%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$15.57M*	$13.15M	$2.43M*	$54.82M	28.41%*	(m)	$14.25M*	$17.64M	$3.66M	(m)	$3.41M
2024-06-30	Reported	$16.76M*	$14.38M	$2.38M*	$55.85M	30.02%*	(m)	$9.63M*	$17.38M	$4.28M	(m)	$3.68M
2024-03-31	Reported	$14.26M	(m)	(m)	(m)	26.66%	(m)	$5.07M	$16.81M	$4.09M	(m)	$2.91M
2023-12-31	Reported	$12.65M	(m)	(m)	(m)	25.88%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$11.57M*	$9.18M	$2.40M*	$47.41M	24.41%*	(m)	$11.82M*	$16.60M	$4.22M	(m)	$2.32M
2023-06-30	Reported	$11.78M*	$9.45M	$2.33M*	$50.12M	23.50%*	(m)	$11.90M*	$18.03M	$4.52M	(m)	$2.22M
2023-03-31	Reported	$10.23M	(m)	(m)	(m)	21.72%	(m)	$2.28M	$16.19M	$3.88M	(m)	$1.98M
2022-12-31	Reported	$9.26M	(m)	(m)	(m)	22.60%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$8.48M*	$6.15M	$2.33M*	$39.03M	21.72%*	(m)	$7.34M*	$13.96M	$3.46M	(m)	$692.00K
2022-06-30	Reported	$8.23M*	$5.78M	$2.44M*	$39.03M	21.08%*	(m)	$9.25M*	$14.30M	$3.35M	(m)	$2.03M
2022-03-31	Reported	$10.3M	(m)	(m)	(m)	26.04%	(m)	$4.71M	$13.60M	$2.93M	(m)	$1.96M
2021-12-31	Reported	$11.19M	(m)	(m)	(m)	28.31%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	$12.00M*	$9.07M	$2.92M*	$38.37M	31.27%*	(m)	$14.07M*	$13.50M	$2.85M	(m)	$1.93M
2021-06-30	Reported	$13.74M*	$11.11M	$2.64M*	$40.67M	33.79%*	(m)	$9.90M*	$13.91M	$2.65M	(m)	$2.16M
2021-03-31	Reported	$10.57M	(m)	(m)	(m)	29.45%	(m)	$6.07M	$12.08M	$2.84M	(m)	$1.56M
2020-12-31	Reported	$12.08M	(m)	(m)	(m)	32.17%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	$12.70M*	$10.02M	$2.68M*	$36.42M	34.88%*	(m)	$14.11M*	$13.71M	$2.10M	(m)	$1.86M
2020-06-30	Reported	$6.51M*	$4.87M	$1.64M*	$24.85M	26.20%*	(m)	$5.35M*	$7.82M	$2.14M	(m)	$1.27M
2020-03-31	Reported	$5.89M	(m)	(m)	(m)	19.28%	(m)	$1.19M	$10.07M	$2.99M	(m)	$1.11M
2019-12-31	Reported	$6.37M	(m)	(m)	(m)	21.11%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$7.25M*	$5.91M	$1.34M*	$29.10M	24.91%*	(m)	$4.47M*	$8.93M	$2.28M	(m)	$706.00K
2019-06-30	Reported	$7.26M*	$5.92M	$1.35M*	$29.48M	24.63%*	(m)	$4.33M*	$9.17M	$2.26M	(m)	$1.46M
2019-03-31	Reported	$5.72M	(m)	(m)	(m)	20.08%	(m)	-$219.00K	$9.02M	$2.24M	(m)	$1.00M
2018-12-31	Reported	$8.41M	(m)	(m)	(m)	29.62%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$5.62M*	$4.61M	$1.01M*	$24.16M	23.25%*	(m)	$4.31M*	$6.91M	$2.04M	(m)	$416.00K
2018-06-30	Reported	$12.61M*	$11.54M	$1.07M*	$27.02M	46.66%*	(m)	$4.88M*	$8.03M	$1.99M	(m)	$2.80M
2018-06-30	Reported	(m)	$11.54M	(m)	$27.02M	(m)	(m)	(m)	$8.03M	$1.99M	(m)	$2.80M
2018-03-31	Reported	$5.9M	(m)	(m)	(m)	22.69%	(m)	$3.75M	$7.52M	$1.82M	(m)	$1.06M
2017-12-31	Reported	$7.41M	(m)	(m)	(m)	28.34%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$6.06M*	$5.05M	$1.00M*	$24.82M	24.40%*	(m)	$8.20M*	$7.25M	$1.76M	(m)	$31.00K
2017-06-30	Reported	$6.52M*	$5.54M	$983.00K*	$25.75M*	25.31%*	(m)	(m)	(m)	$1.63M	(m)	$834.00K
2017-06-30	Reported	(m)	$5.54M	(m)	$25.75M	(m)	(m)	(m)	$8.24M	$1.63M	(m)	$833.00K
2017-03-31	Reported	$5.17M	(m)	(m)	(m)	21.43%	(m)	(m)	(m)	$1.66M	(m)	$1.02M
2016-12-31	Reported	$4.84M	(m)	(m)	(m)	20.79%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$6.19M*	$5.34M	$846.00K*	(m)	(m)	(m)	(m)	(m)	$1.54M	(m)	$2.08M
2016-06-30	Reported	$4.71M*	$3.78M	$931.00K*	(m)	(m)	(m)	(m)	(m)	$1.63M*	(m)	$1.24M*
2016-06-30	Reported	(m)	$3.78M	(m)	(m)	(m)	(m)	(m)	(m)	$1.63M	(m)	$1.24M
2016-03-31	Reported	$4.18M	(m)	(m)	(m)	20.64%	$720.00K	(m)	(m)	$1.45M	(m)	$1.10M
2015-12-31	Reported	$3.99M	(m)	(m)	(m)	19.46%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	$4.15M*	$3.32M	$825.00K*	(m)	(m)	$765.00K*	(m)	(m)	$1.42M	(m)	$1.05M
2015-06-30	Reported	(m)	$2.79M	(m)	(m)	(m)	(m)	(m)	(m)	$1.33M	(m)	$1.06M
2015-03-31	Reported	$3.14M	(m)	(m)	(m)	16.58%	$323.00K	(m)	(m)	$1.15M	(m)	$957.00K
2014-12-31	Reported	$3.65M	(m)	(m)	(m)	19.54%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$2.65M*	$1.85M	$802.00K*	(m)	(m)	$225.00K*	(m)	(m)	$1.11M	(m)	$965.00K
2014-06-30	Reported	$2.77M*	$1.98M	$789.00K*	(m)	(m)	$116.00K*	(m)	(m)	$1.14M	(m)	$728.00K
2014-03-31	Reported	$600,000.00	(m)	(m)	(m)	3.58%	$433.00K	(m)	(m)	$1.34M	(m)	-$66.00K
2013-12-31	Reported	$1.99M	(m)	(m)	(m)	11.11%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	$1.50M*	$776.00K	$723.00K*	(m)	(m)	$380.00K*	$2.39M*	(m)	$1.30M	(m)	$64.00K
2013-06-30	Reported	$2.09M*	$1.45M	$641.00K*	(m)	(m)	$1.38M*	$1.99M*	(m)	$1.27M	(m)	$486.00K
2013-03-31	Reported	$1.73M	(m)	(m)	(m)	11.27%	$676.00K	-$346.00K	(m)	$1.27M	(m)	$224.00K
2012-12-31	Reported	$1.53M	(m)	(m)	(m)	10.34%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	$1.53M*	$1.00M	$528.00K*	(m)	(m)	$204.00K*	$1.86M*	(m)	$1.26M	(m)	$392.00K
2012-06-30	Reported	$2.01M*	$1.46M	$557.00K*	(m)	(m)	$313.00K*	$2.04M*	(m)	$1.14M	(m)	$596.00K
2012-03-31	Reported	$1.4M	(m)	(m)	(m)	10.07%	$271.00K	$386.00K	(m)	$1.14M	(m)	$277.00K
2011-12-31	Reported	$1.4M	(m)	(m)	(m)	10.46%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	$2.51M*	$1.99M	$516.00K*	(m)	(m)	$650.00K*	$2.38M*	(m)	$974.00K	(m)	$732.00K
2011-06-30	Reported	$1.39M*	$897.00K	$489.00K*	(m)	(m)	$239.00K*	$3.51M*	(m)	$1.04M	(m)	$385.00K
2011-03-31	Reported	$431,000.00	(m)	(m)	(m)	2.95%	$515.00K	-$2.41M	(m)	$1.27M	(m)	$54.00K
2010-12-31	Reported	-$926,000.00	(m)	(m)	(m)	-6.42%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$2.35M*	$2.03M	$314.00K*	(m)	(m)	$542.00K*	$2.62M*	(m)	$1.14M	(m)	$548.00K
2010-06-30	Reported	(m)	$2.01M	(m)	(m)	(m)	(m)	(m)	(m)	$1.34M	(m)	$452.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$78.33M	(m)	(m)	(m)	31.38%	(m)	$81.25M	$71.06M	$14.14M	(m)	$17.45M
2024-12-31	Reported	$61.86M	(m)	(m)	(m)	28.14%	(m)	$44.12M	$68.96M	$15.65M	(m)	$12.84M
2024-09-30	Rolling	(m)	$49.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-06-30	Rolling	(m)	$45.64M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-03-31	Rolling	(m)	$40.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-12-31	Reported	$46.23M	(m)	(m)	(m)	23.89%	(m)	$36.75M	$66.44M	$16.97M	(m)	$9.37M
2023-12-31	Rolling	(m)	$36.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Rolling	(m)	$33.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-06-30	Rolling	(m)	$30.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-03-31	Rolling	(m)	$26.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-12-31	Reported	$36.26M	(m)	(m)	(m)	22.43%	(m)	$25.38M	$56.76M	$13.29M	(m)	$6.85M
2022-12-31	Rolling	(m)	$26.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Rolling	(m)	$28.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-06-30	Rolling	(m)	$31.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-03-31	Rolling	(m)	$36.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-12-31	Reported	$47.5M	(m)	(m)	(m)	30.76%	(m)	$35.10M	$53.04M	$11.80M	(m)	$7.38M
2021-12-31	Rolling	(m)	$36.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Rolling	(m)	$37.67M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	$38.61M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	$32.38M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	$37.18M	(m)	(m)	(m)	28.74%	(m)	$34.80M	$44.75M	$10.10M	(m)	$6.14M
2020-12-31	Rolling	(m)	$28.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	$24.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	$20.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	$21.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	$26.6M	(m)	(m)	(m)	22.69%	(m)	$14.18M	$37.38M	$9.28M	(m)	$3.75M
2019-12-31	Rolling	(m)	$21.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	$23.45M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	$22.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	$32.53M	(m)	(m)	(m)	30.82%	(m)	$19.51M	$31.63M	$8.20M	(m)	$5.50M
2017-12-31	Reported	$25.16M	(m)	(m)	(m)	24.94%	(m)	$22.87M	$30.17M	$6.64M	(m)	$3.93M
2016-12-31	Reported	$19.93M	(m)	(m)	(m)	22.35%	$2.84M	$16.90M	$26.21M	$6.14M	(m)	$5.65M
2015-12-31	Reported	$14.91M	(m)	(m)	(m)	19.03%	$2.27M	(m)	(m)	$5.48M	(m)	$3.67M
2014-12-31	Reported	$9.67M	(m)	(m)	(m)	13.61%	$1.17M	(m)	(m)	$4.67M	(m)	$2.40M
2013-12-31	Reported	$7.31M	(m)	(m)	(m)	11.33%	$2.73M	$5.39M	(m)	$5.24M	(m)	$1.13M
2012-12-31	Reported	$6.47M	(m)	(m)	(m)	11.41%	$1.21M	$4.72M	(m)	$5.09M	(m)	$1.42M
2011-12-31	Reported	$5.73M	(m)	(m)	(m)	9.93%	$2.02M	$3.17M	(m)	$4.42M	(m)	$1.61M
2010-12-31	Reported	$5.39M	(m)	(m)	(m)	9.62%	$2.47M	$7.05M	(m)	$5.49M	(m)	-$1.99M
2009-12-31	Reported	$3.37M	(m)	(m)	(m)	6.62%	$577.00K	$5.44M	(m)	$5.91M	(m)	$617.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NovoCure Ltd (NVCR)		$1.886B	-11.87
Inspire Medical Systems, Inc. (INSP)	United States	$1.990B	9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)	United States	$1.535B	-9.02
Alphatec Holdings, Inc. (ATEC)	United States	$1.531B	-12.14
UFP TECHNOLOGIES INC (UFPT)	United States	$2.308B	28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)	United States	$1.234B	-193.02
ARTIVION, INC. (AORT)	United States	$1.123B	-345.09
IRADIMED CORP (IRMD)	United States	$1.089B	52.92
TANDEM DIABETES CARE INC (TNDM)	United States	$1.059B	-16.57
PROCEPT BioRobotics Corp (PRCT)	United States	$1.001B	-11.77